RxDoctor Payments Data

Mustafa Saidi, MD

Hospitalist · Fredericksburg, VANPI 1760795611

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $527 of the $654 with a category attached, or 80.5%. It is spread thinly across 11 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $485 and has fallen 98.9% since, to $5 in 2024. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$654in general payments, 2019–2025

Across 18 payments — averaging $36.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Enterprises LLC$146
  • Otsuka America Pharmaceutical, Inc.$122
  • Vifor Pharma, Inc.$103
  • Bayer$65
  • Amgen$57
  • Medtronic$55
  • plus $107 from 5 others

What the payments were for

  • Food & beverage$52781%
  • Education$12819%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$654 in reported general payments places this provider in the 90th percentile of 539 hospitalist providers in Virginia.

See all hospitalist providers in Virginia

Medicare billing

Part B allowed, 2024
$147,269
Medicare patients
492
Services billed
1,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol52$37,487
JardianceEmpagliflozin23$21,006
Bumetanide34$3,329
Sevelamer Carbonate27$2,799
Olmesartan Medoxomil138$2,186
Clonidine14$919
Allopurinol83$888
Calcitriol42$796
Chlorthalidone64$521
Amlodipine Besylate54$402
Torsemide27$392
Furosemide38$366
Losartan Potassium25$237
Lisinopril22$111
Atorvastatin Calcium16$61

Paid to pharmacies, not to this prescriber.

Other hospitalist in Fredericksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →